6Devaraj S,Xu DY,Jialal I. C-reactive protein increases plasminogen activator inhbitor-Ⅰ expression and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis[J].Circulation,2003,(03):398-404.
3Ghassibe-Sabbagh M,Platt DE,Youhanna S,et al. Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk[J ].Atherosclero- sis, 2012,222( 1 ) : 180-186.
4Prisant L M, Zemel P C, Nichols F T, et aI.Carotid plaque associa- tions among hypertensive patients[J].Arch Intern Med, 1993, 153 (4):501-506.
6Stone N J, Robinson J, Lichtenstein A H,et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults:A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J/OL]. Circulation, 2013 [2013-11-10]http://www. nci. nih. gov/pumed/24222016.
7Kotsa~tis P, Ntaios G, Savopoulos C, et al. Trend in incidence of cardiovascular risk {actors in elderly and over-aged stroke patients between 2003 and 2007 in GreeceEJ~. Arch Gerontol Geriatr,2010,50(3) :31-35.
8Phankingthongkum R, Panchavinnin P, Chinthammitr Y, et al. High on-clopidogrel treatment platelet reactivity in Thai patients with chronic stable angina scheduled for percutaneous coronary intervention[J]. J Med Assoc Thai, 2013,96 (5) 538-543.
